Literature DB >> 1532736

Does (or should) chronologic age influence the choice of cancer treatment?

P A Ganz1.   

Abstract

With rare exceptions, age alone should not determine the diagnostic and therapeutic plan for the management of cancer. Unfortunately, a number of studies show that older individuals have more advanced stages of certain cancers than younger persons, and that this is probably the result of less intensive screening in the elderly. For example, fewer elderly women receive regular breast palpation, mammograms, and pelvic examinations, even though older women are at higher risk for breast and gynecologic cancers. In addition, several studies suggest that older persons may not be treated as appropriately as younger persons, even taking into account complicating medical conditions. In brief, there seems to be considerable age bias by physicians in offering cancer screening and treatment to elderly patients. In addition, elderly persons sometimes contribute to these difficulties by failing to obtain screening tests that are recommended.

Entities:  

Mesh:

Year:  1992        PMID: 1532736

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  3 in total

1.  A population-based study on variations in the use of adjuvant systemic therapy on postmenopausal patients with early stage breast cancer.

Authors:  G Nagel; B Röhrig; H Hoyer; U Wedding; D Katenkamp
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-23       Impact factor: 4.553

Review 2.  Perspectives on quality of life of older patients with cancer.

Authors:  L Balducci
Journal:  Drugs Aging       Date:  1994-04       Impact factor: 3.923

3.  Surgical and regional treatments for colorectal cancer metastases in older patients: A systematic review and meta-analysis.

Authors:  Nicola de'Angelis; Capucine Baldini; Raffaele Brustia; Patrick Pessaux; Daniele Sommacale; Alexis Laurent; Bertrand Le Roy; Vania Tacher; Hicham Kobeiter; Alain Luciani; Elena Paillaud; Thomas Aparicio; Florence Canuï-Poitrine; Evelyne Liuu
Journal:  PLoS One       Date:  2020-04-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.